Tucatinib,Trastuzumab,fulvestrant
Seagen
['trastuzumab,(-trastuzumab deruxtecan),(-trastuzumab-deruxtecan)', 'tucatinib']
combination of trastuzumab and tucatinib shows good activity in her2 pos btc. #asco23 #asco2023 #asco 
A dedicated conference for oncology held under the theme "Access. Educate. Collaborate"